MARKET REPORT: Synairgen soars 27% as US authorities agree to step up trials of the UK drug maker’s Covid treatment By Francesca Washtell For The Daily Mail Published: 21:51 GMT, 18 December 2020 | Updated: 21:51 GMT, 18 December 2020 The string of Covid vaccines in development has been in the spotlight for weeks. But … Read more
SMALL CAP MOVERS: Synairgen is worth 20 times what it was a year ago while Alien Metals keeps up its impressive share price run By Giulia Bottaro At Proactive Investors For Thisismoney.co.uk Published: 16:50 BST, 16 October 2020 | Updated: 16:52 BST, 16 October 2020 Synairgen this week completed an £80million share placing to support … Read more
MIDAS SHARE TIPS UPDATE: Time to cash in half your shares in Covid drug firm Synairgen By Joanne Hart for The Mail on Sunday Published: 22:27 BST, 25 July 2020 | Updated: 23:16 BST, 25 July 2020 At the start of this year, shares in Synairgen were valued at less than 6p. By July 17, … Read more
How Woodford’s old bet Synairgen quadrupled in value after positive data from coronavirus treatment trial… SMALL CAP MOVERS By Calum Muirhead At Proactive Investors For Thisismoney Published: 12:25 BST, 24 July 2020 | Updated: 12:37 BST, 24 July 2020 A blockbuster stock on AIM this week was Synairgen, which rocketed 412 per cent higher to … Read more
Drug duo Astrazeneca and Synairgen shares soar as they declare major breakthroughs in battle to develop Covid vaccine and treatment By Matt Oliver For The Daily Mail Published: 21:50 BST, 20 July 2020 | Updated: 22:15 BST, 20 July 2020 Pioneering British drugs companies declared major breakthroughs in the battle against coronavirus yesterday – sending … Read more
More misery for Woodford investors as Synairgen shares – which were sold by fund administrators – rocket 550% By Daily Mail City & Finance Reporter Published: 21:51 BST, 20 July 2020 | Updated: 22:23 BST, 20 July 2020 Investors trapped in Neil Woodford’s former flagship fund have missed out on a huge windfall after administrators … Read more